Ribociclib (Kisqali, Novartis) is one of a class of drugs known as CDK4/6 inhibitors, which have recently been introduced to NHS care and work by...

3 June 2019

The Scottish Medicines Consortium (SMC) has today (13 May 2019) announced its decision to approve breast cancer drug abemaciclib as part of two new...

13 May 2019

The National Audit of Breast Cancer in Older Patients (NABCOP), carried out by the Royal College of Surgeons and the Association of Breast Surgery,...

10 May 2019

New research presented at the European Congress on Obesity has suggested that nutrients called phenolic acids – which are found in foods such as...

2 May 2019

Breast Cancer Care and Breast Cancer Now respond to a report on cancer incidence in Scotland.  Ashleigh Simpson, Policy and Campaigns...

1 May 2019

The Clinical Risk Assessment report follows a previous report from Health Improvement Scotland which highlighted that patients in NHS Tayside...

17 April 2019

The National Institute for Health and Care Excellence (NICE) has today (10 April 2019) provisionally rejected breast cancer drug ribociclib in...

10 April 2019

Health Improvement Scotland has issued a report into the clinical management of breast cancer in NHS Tayside which highlights local inconsistencies...

5 April 2019

The National Institute for Health and Care Excellence (NICE) has today published draft guidance recommending breast cancer drug abemaciclib with...

2 April 2019